Literature DB >> 26298039

A pathologically proven case of adult-onset HIV-related lymphocytic interstitial pneumonia with acute exacerbation treated with steroid and antiretroviral therapy.

Makoto Saito1, Shuji Hatakeyama2, Yoshitaka Wakabayashi1, Shintaro Yanagimoto1, Tamiko Takemura3, Hiroshi Yotsuyanagi1.   

Abstract

Lymphocytic interstitial pneumonia (LIP) is a rare opportunistic illness in human immunodeficiency virus (HIV)-infected adults, although it is relatively common among HIV-infected children. Most adult cases have been reported in African and Afro-Caribbean patients and few cases have been reported from Asia. Acute exacerbation of HIV-related LIP has not been well described. Here we report a pathologically proven case of acute exacerbation of adult-onset HIV-related LIP. The patient was an African immigrant living in Japan who presented with chronic dyspnea and diffuse bilateral pulmonary infiltrates. His clinical, radiological, and pathological findings were consistent with those of LIP. After a diagnostic surgical lung biopsy, his hypoxemia and pulmonary infiltrates exacerbated rapidly over a few days, although his condition had not progressed during the previous year. LIP may be an important differential diagnosis among adult patients in Asian countries, especially patients of non-Asian ethnicity.
Copyright © 2015 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adult onset; Antiretroviral therapy; Human immunodeficiency virus; Lymphocytic interstitial pneumonia; Lymphoproliferative disorder

Mesh:

Substances:

Year:  2015        PMID: 26298039     DOI: 10.1016/j.jiac.2015.07.008

Source DB:  PubMed          Journal:  J Infect Chemother        ISSN: 1341-321X            Impact factor:   2.211


  1 in total

1.  A histologically proven case of lymphocytic interstitial pneumonia in a HIV infected adult with an undetectable viral load.

Authors:  Sarah Assaf; Pujan Patel; David Stoeckel
Journal:  Respir Med Case Rep       Date:  2017-02-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.